Hashimoto thyroiditis: A century later

Advances in Anatomic Pathology

Volumn 19, Issue 3, 2012, Pages 181-186

  Ahmed, Rania ^a   Al Shaikh, Safa ^a   Akhtar, Mohammed ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

autoimmune; carcinoma; Hashimoto; IgG4; lymphoma; thyroiditis

Indexed keywords

IMMUNOGLOBULIN G4; IODOTYROSINE; LEUKOCYTE ANTIGEN; THYROGLOBULIN;

ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; DISEASE ASSOCIATION; DISEASE COURSE; GIANT CELL; HASHIMOTO DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LOBECTOMY; LYMPHOCYTIC INFILTRATION; LYMPHOID TISSUE; NONHODGKIN LYMPHOMA; PATHOGENESIS; PRIORITY JOURNAL; RETROPERITONEAL FIBROSIS; REVIEW; RIEDEL THYROIDITIS; THYROID CARCINOMA; THYROID CELL; THYROID FOLLICLE; THYROIDECTOMY; THYROIDITIS;

DIET; DISEASES IN TWINS; FEMALE; HASHIMOTO DISEASE; HUMANS; IMMUNOGLOBULIN G; IODINE; THYROID NEOPLASMS; TWINS, MONOZYGOTIC;

EID: 84860014561     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/PAP.0b013e3182534868     Document Type: Review

References (51)

1. Sawin CT. The heritage of Dr. Hakaru Hashimoto (1881- 1934). Endocr J. 2002;49:399-403.
2. Vanderpump MP, Turnbridge WM, French JM. The incidence of thyroid disorders in a community: twenty year follow up of Wickham Survey. Clin Endocrinol. 1995;43:55-68.
3. Wiebolt J, Achterbergh R, den Boer A, et al. Clustering of additional autoimmunity behaves differently in Hashimoto's patients compared with Graves' patients. Eur J Endocrinol. 2011;164:789-794.
4. Vanderpump MP, French JM, Appleton D. The prevalence of hyperprolactinaemia and association with markers of autoimmune thyroid disease in survivors of the Whickham Survey cohort. Clin Endocrinol (Oxf). 1998;48:39-44. (Pubitemid 28122431)
5. Wang C, Crapo LM. The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am. 1997;26:189-218. (Pubitemid 27123901)
6. Chistiakov DA. Immunogenetics of Hashimoto's thyroiditis. J Autoimmune Dis. 2005;2:1-21.
7. Tomer Y, Huber A. The etiology of autoimmune thyroid disease; a story of genes and environment. J Autoimmun. 2009;32:231-239.
8. Tod JA, Acha-Orbea H, Bell JI, et al. Science. 1988;240: 1003-1009.
9. Menconi F, Monti MC, Greenberg DA, et al. Molecular amino acid signatures in the MHC class II peptide bonding pocket predisposes to auto immune thyroiditis in human and in mice. Proc Natl Acad Sci USA. 2008;105:14034-14039.
10. Braun J, Donner H, Siegmund T, et al. CTLA-4 promotor variants in patients with Graves disease and Hashimoto's thyroiditis. Tissue Antigens. 1998;51:563-566. (Pubitemid 28269228)
11. Ueda H, Howson JM, Esposito L, et al. Association of T cell regulatory gene CTLA-4 with susceptibility to autoimmune disease. Nature. 2003;423:506-511. (Pubitemid 36648570)
12. Nithyanathan R, Howard JM, Allahbadia A, et al. Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom. Thyroid. 2002;12:3-6.
13. Criswell LA, Pfeiffer KA, Lum RF, et al. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTMN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet. 2005;76:561-571. (Pubitemid 40432164)
14. Ringold DA, Nicoloff JT, Kesler M, et al. Further evidence for a strong genetic influence on the development of autoimmune thyroid disease: the California twin study. Thyroid. 2002; 12:647-653. (Pubitemid 34913236)
15. Phillips DI, Osmond C, Baird J, et al. Is birthweight associated with thyroid autoimmunity? A study in twins. Thyroid. 2002; 12:377-380. (Pubitemid 34602595)
16. Brix TH, Kyvik KO, Hegedus L. A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab. 2000;85:536-539. (Pubitemid 32273630)
17. Ebner SA, Lueprasitsakul W, Alex S, et al. Iodine content of rat thyroglobulin affects its autogenicity in inducing lympholytic thyroiditis in the BB/Wor rat. Autoimmunity. 1992; 13:209-214.
18. Rasooly L, Rose NR, Saboori AM, et al. Iodine is essential for human T cell recognition of human thyroglobulin. Autoimmunity. 1998;27:213-219. (Pubitemid 28242888)
19. Mahmoud I, Colin I, Many MC, et al. Direct toxic effect effect of iodide in excess on iodine-deficient thyroid gland: epithelial necrosis and inflammation associated with lipofuscin accumulation. Exp Mol Pathol. 1986;44:259-271. (Pubitemid 16012120)
20. Allen EM, Appel MC, Braverman LE. The effect of iodide ingestion on the development of spontaneous lympholytic thyroiditis in the diabetes prone BB/W rat. Endocrinology. 1986;118:1977-1981. (Pubitemid 16106799)
21. Rosai J, Tallini G. Rosai and Ackerman's Surgical Pathology, Chapter 9, Vol 1. 10th ed. New York: Mosby; :488-539.
22. Hsi ED, Singleton TP, Svoboda SM, et al. Characterization of the lymphoid infiltrate in Hashimoto thyroiditis by immunohistochemistry and polymerase chain reaction for immunoglobulin heavy chain gene rearrangement. Am J Clin Pathol. 1998;110:327-333. (Pubitemid 28406990)
23. Knecht H, Saremaslani P, Hedinger Chr E. Immunohistological findings in Hashimoto's thyroiditis, focal lymphocytic thyroiditis and thyroiditis de Quervain. Comparative study. Virchows Arch [A]. 1981;393:215-231. (Pubitemid 11015814)
24. Katz SM, Vickery AL. The fibrous variant of Hashimoto's thyroiditis. Hum Pathol. 1974;5:161-170.
25. Harach HR, Williams ED. Fibrous thyroiditis: an immunopathological study. Histopathology. 1983;7:739-751.
26. Cheuk W, Chan JKC. IgG4-related sclerosing disease: a clinical appraisal of an evolving clinicopathologic entity. Adv Anat Pathol. 2010;17:303-332.
27. Zen Y, Nakamura Y. IgG4 related disease: a cross-sectional study of 104 cases. Am J Surg Pathol. 2010;34:1812-1819.
28. Nirula A, Glaser SM, Kalled SL, et al. What is IgG4? A review of the biology of a unique immunoglobulin subtype. Curr Opin Rheumatol. 2011;23:119-124.
29. Li Y, Bai Y, Liu Z, et al. Immunohistochemistry of IgG4 can help subclassify Hashimoto's immune thyroiditis. Pathol Int. 2009;59:636-641.
30. Li Y, Nishihara E, Mirokova M, et al. Distinct clinical, serological and sonographic characteristics of Hashimoto's thyroiditis based with and without IgG4 positive plasma cells. J Clin Endocrinol Metab. 2010;95:1309-1317.
31. Dahlgren M, Khosroshahi A, Nielsen GP, et al. Riedel's thyroiditis and fultifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res. 2010;62:1312-1318.
32. Hay ID. Thyroiditis: a clinical update. Mayo Clin Proc. 1985;60:836-843. (Pubitemid 16206009)
33. Brady OH, Hehir DG, Hefferman SJ. Riedel's thyroiditis: case report and literature review. Ir J Med Sci. 1994;163:176-177. (Pubitemid 24144227)
34. Papi G, LiVolsi VA. Current concepts on Riedel thyroiditis. Am J Clin Pathol. 2004;121(suppl):S50-S63.
35. Baloch ZW, Feldman MD, LiVolsi VA. Combined Riedel's disease and fibrosing Hashimoto's thyroiditis: a report of three cases with two showing coexisting papillary carcinoma. Endocr Pathol. 2000;11:157-163. (Pubitemid 30610125)
36. Li Y, Nishihara E, Kakudo K. Hashimoto's thyroiditis: old concepts and new insights. Curr Opin Rheumatol. 2011;23:102-107.
37. Dailey ME, Lindsay S, Skahen R. Relation of thyroid neoplasms to Hashimoto disease of thyroid gland. Arch Surg. 1955;70:291-297.
38. Kim KW, Park YJ, Kim EH, et al. Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto's thyroiditis. Head Neck. 2011;33:691-695.
39. Ott RA, McCall AR, McHenry C, et al. The incidence of thyroid carcinoma in Hashimoto's thyroiditis. Am Surg. 1987;53:442-443.
40. Okayasu I, Fujiwara M, Hara Y, et al. Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, white and African Americans. Cancer. 1995;76:2312-2318.
41. Strauss M, Laurian N, Atebi E. Coexistent carcinoma of the thyroid gland and Hashimoto's thyroiditis. Surg Gynecol Obstet. 1983;157:228-232. (Pubitemid 13007110)
42. Repplinger D, Bergen A, Zhang Y, et al. Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer? J Surg Research. 2008;150:49-52.
43. Cunha LL, Ferreira RC, Marcello MA, et al. Clinical and pathological implications of concurrent autoimmune thyroid disorders and papillary thyroid cancer. J Thyroid Res. 2011; [Epub ahead of print Feb 17, 2011].
44. Burstein DE, Nagi C, Wang BY, et al. Immunohistochemical detection of p53 homlog p63 in solid cell nests, papillary carcinoma and Hashimoto's thyroiditis: a stem cell hypothesis of papillary carcinoma oncogenesis. Hum Pathol. 2004;35:465-473. (Pubitemid 38507084)
45. Cameselle-Teijeiro J, Febles-Perez C, Sobrinho-Simoes M. Papillary and mucoepiidermoid carcinoma of the thyroid with anaplastic transformation. A case report with histological and immunohistochemical findings that support a provocative histogenetic hypothesis. Pathol Res Pract. 1995;191:1214-1221. (Pubitemid 26060404)
46. Cameselle-Teijeiro J, Abdulkader I, Perez-Becerra R, et al. BRAF mutation in solid cell nest hyperplasia associated with papillary thyroid carcinoma. A precursor lesion? Hum Pathol. 2009;40:1029-1035.
47. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972;29:252-260.
48. Pedersen RK, Pedersen NT. Primary non-Hodgkin's lymphoma of the thyroid gland: a population based study. Histopathology. 1996;28:25-32. (Pubitemid 26040138)
49. Wolf BC, Sheahan K, DeCoste D, et al. Immunohistochemical analysis of small cell tumors of the thyroid gland: an Eastern Cooperative Oncology Group study. Hum Pathol. 1992;23: 1252-1261.
50. Hyjek E, Isaacson PG. Primary B cell lymphoma of the thyroid and its relationship to Hashimoto's thyroiditis. Hum Pathol. 1988;19:1315-1326. (Pubitemid 19005633)
51. Abdul-Rahman ZH, Gogas SJ, Tooze JA, et al. T-cell lymphoma in Hashimoto's thyroiditis. Histopathology. 1996; 29:455-459. (Pubitemid 26384179)